The data suggest that cytokine upregulation of TIMP-1 and coordinate downregulation of MMP-2 expression might control the molar ratio of TIMP-1 and MMP-2 to influence the level of protease activity and invasive behaviour of malignant prostate cancer cells. The gene discussed is TIMP1; the disease is prostate carcinoma.